The launch of the 750mcg teriparatide injection in Australia has seen controlled sales to date. Primarily designated for patients with severe osteoporosis who have not responded to other therapies , access is strictly managed. Current supply levels are tight , and sufferers should confirm from their physician the latest details on obtaining this me